Curanex Pharmaceuticals Inc
(CURX)Financial Statements · SEC EDGAR XBRL
Net Income
-$4.2M
-1068.8%
EPS
$-0.17
-466.7%
Op. Income
-$4.2M
-1061.2%
Source: SEC EDGAR XBRL
Breakdown
Revenues
Operating Expenses & Income
Research & Development
Total Operating Expenses
Operating Income
Non-Operating Income/Expense
Net Income
EPS (Basic)
EPS (Diluted)
Shares Outstanding (Diluted)